ChartRow logo
TNDM
$16.52+0.85%
as of close, Oct 20, 2026
☾ AH $16.52 +0.85%
PeersMRNALLYMDTUNHJNJTMO
Share this page

TNDM financial statements

The full income statement, balance sheet, and cash-flow statement for Tandem Diabetes Care Inc. (TNDM), plus valuation ratios — straight from SEC filings. Switch between annual, quarterly, and trailing-twelve-month figures, pick how far back to look, and flip the time order. Every line has a trend sparkline.

Shares outstanding (point-in-time)

2024-06 65.5M2024-09 65.7M2024-12 66.5M2025-03 66.6M2025-06 67.6M2025-09 67.8M2025-12 68.3M2026-03 68.5M2026-06 69.6M+6.3% over 8 periods

SEC-filed end-of-period counts (cover pages and balance sheets, split-adjusted) — the series realized buyback yield is computed from. The weighted-average share lines in the statements below lag these by design: an average over the year sits near the midpoint of an ongoing buyback.

PeriodRangeOrderChangeFiguresAs-reported fiscal years.
Line itemTrendFY2025FY2024FY2023FY2022FY2021
Income Statementas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Revenue1.01B+7.9%940M+25.7%748M-6.7%801M+14.0%703M+40.9%
546M+11.5%490M+33.1%368M-11.0%413M+9.8%376M+44.4%
Cost of revenue469M+4.0%451M+18.6%380M-2.1%388M+18.9%327M+37.0%
733M+24.6%589M-2.0%601M+18.8%506M+43.1%354M+31.7%
Research & development193M-2.9%199M+17.2%170M+22.0%139M+51.1%92.1M+44.8%
Selling, general & administrative445M+14.2%390M+10.6%353M+5.0%336M+28.4%262M+27.6%
Amortization of intangibles2.50M+31.6%1.90M+0.0%1.90M-5.0%2.00M-9.1%2.20M+83.3%
Provision for credit losses9.48M-5.0%9.98M+80.1%5.54M+15.9%4.78M+105.0%2.33M-22.6%
Operating income-187M-88.9%-99.1M+57.5%-233M-151.2%-92.8M-509.9%22.7M+384.7%
Interest expense7.91M+6.6%7.42M-25.0%9.88M+59.2%6.21M—
Other non-operating income-13.0M-279.3%7.26M-44.1%13.0M+324500.0%-4.00K+99.9%-6.75M+76.2%
Equity-method income-14.2M-591.4%-2.05M0.000.00—
Pre-tax income-200M-118.0%-91.9M+58.3%-220M-137.2%-92.9M-683.9%15.9M+143.8%
Income tax4.44M+6.8%4.16M+76.3%2.36M+35.3%1.74M+420.0%335K+117.6%
-205M-113.2%-96.0M+56.9%-223M-135.3%-94.6M-707.7%15.6M+145.3%
Net income to common——-223M-135.3%-94.6M-707.7%15.6M+145.3%
-$3.04-106.8%-$1.47+57.1%-$3.43-133.3%-$1.47-712.5%$0.24+142.9%
EPS (basic)-$3.04-106.8%-$1.47+57.1%-$3.43-133.3%-$1.47-688.0%$0.25+144.6%
Weighted-avg shares (basic)67.3M+2.8%65.5M+0.7%65.0M+1.3%64.1M+1.8%63.0M+3.3%
Weighted-avg shares (diluted)67.3M+2.8%65.5M+0.7%65.0M+1.3%64.1M-0.3%64.3M+5.5%
Balance Sheetas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
618M-14.7%724M-3.1%748M-12.0%850M+4.7%812M+27.4%
Cash & equivalents90.6M+30.9%69.2M+17.6%58.9M-65.9%173M+142.4%71.2M-24.8%
Short-term investments202M-45.3%369M-9.8%409M-8.0%444M-19.6%553M+41.6%
Accounts receivable165M+44.4%115M+8.6%106M-8.0%115M+3.6%111M+34.7%
Inventory129M-13.9%150M-5.3%158M+42.1%111M+62.1%68.6M+7.6%
Prepaid expenses31.2M+42.1%22.0M+32.4%16.6M+129.0%7.24M-14.1%8.43M+32.1%
881M-8.9%968M+1.6%953M-9.5%1.05B+16.3%905M+26.3%
Property, plant & equipment83.6M+6.9%78.2M+2.1%76.5M+11.7%68.6M+36.1%50.4M+0.7%
Operating lease right-of-use96.2M+12.7%85.3M-2.8%87.8M-20.6%111M+302.2%27.5M+39.1%
Intangible assets11.7M+1167.0%925K-66.7%2.78M-40.0%4.63M-30.3%6.64M
Other non-current assets22.9M+342.6%5.17M-87.2%40.3M+70.7%23.6M+50.2%15.7M+67.6%
243M-1.8%247M+26.5%195M+18.1%165M+25.4%132M+27.0%
Accounts payable47.1M+5.2%44.7M-9.8%49.6M-11.0%55.7M+98.8%28.0M+57.4%
Accrued liabilities21.0M+15.6%18.2M+42.8%12.7M+32.6%9.60M+1.9%9.42M+96.9%
Deferred revenue9.53M-19.5%11.8M-73.1%44.0M+133.6%18.8M+85.0%10.2M+67.4%
Short-term & current debt—40.7M0.00——
Current lease liability19.5M+6.9%18.2M+6.7%17.1M+30.0%13.1M+41.4%9.28M-1.5%
Other current liabilities75.2M+52.6%49.3M+73.3%28.5M-2.9%29.3M+25.4%23.4M+34.9%
726M+3.0%705M+10.3%639M+4.3%613M+29.8%472M+34.8%
Long-term debt310M+0.6%308M+8.2%285M——
Deferred revenue (non-current)8.47M-18.9%10.5M-21.6%13.3M-21.0%16.9M-0.4%16.9M
Non-current lease liability115M+8.0%106M-6.3%114M-8.1%124M+416.4%23.9M+50.3%
Operating lease liability (total)134M+7.9%125M-4.6%131M-4.4%137M+311.6%33.2M+31.0%
Other non-current liabilities49.7M+53.7%32.4M+1.7%31.8M+33.1%23.9M+34.1%17.8M-34.8%
155M-41.0%263M-16.1%314M-28.7%440M+1.6%433M+18.2%
Common stock68.0K+3.0%66.0K+0.0%66.0K+1.5%65.0K+1.6%64.0K+3.2%
Additional paid-in capital1.40B+6.8%1.31B+3.9%1.26B+8.0%1.17B+9.6%1.07B+4.2%
Retained earnings-1.25B-19.5%-1.05B-10.1%-952M-30.5%-729M-14.9%-635M+3.7%
Accumulated other comprehensive income5.59M+387.3%-1.95M-242.2%1.37M+175.3%-1.82M-195.0%-616K-380.0%
Total liabilities & equity881M-8.9%968M+1.6%953M-9.5%1.05B+16.3%905M+26.3%
Common shares issued68.3M+3.1%66.3M+1.1%65.6M+1.6%64.5M+1.1%63.8M+2.4%
Common shares outstanding68.3M+3.1%66.3M+1.1%65.6M+1.6%64.5M+1.1%63.8M+2.4%
Shares outstanding (cover)68.3M+2.8%66.5M+1.3%65.6M+1.7%64.5M+1.0%63.9M+2.2%
Cash Flowas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
-9.72M-140.1%24.2M+176.2%-31.8M-163.0%50.5M-54.7%111M+351.4%
Depreciation & amortization17.7M+6.4%16.6M+5.7%15.7M+9.7%14.3M+3.5%13.8M+32.5%
Intangible amortization2.50M+31.6%1.90M+0.0%1.90M-5.0%2.00M-9.1%2.20M+83.3%
Share-based compensation92.4M-8.9%101M+15.1%88.1M+3.7%84.9M+39.8%60.8M+4.0%
Deferred income taxes0.000.000.000.000.00+100.0%
Change in receivables56.8M+173.2%20.8M+586.2%-4.28M-154.6%7.83M-74.7%31.0M-20.2%
Change in inventory-24.8M-327.1%-5.81M-112.6%46.1M+8.5%42.5M+756.9%4.95M-67.7%
Change in payables2.23M+193.1%-2.39M+50.8%-4.86M-119.9%24.5M+138.4%10.3M+819.1%
Other operating activities4.36M+524.8%-1.03M-299.4%515K-47.9%988K-58.8%2.40M+12726.3%
72.9M+410.3%-23.5M+72.6%-85.7M-358.5%33.2M+117.7%-187M+36.9%
Capital expenditure19.9M+3.7%19.2M-28.3%26.8M-21.4%34.1M+140.5%14.2M-48.3%
Free cash flow-29.7M-694.1%4.99M+108.5%-58.6M-458.1%16.4M-83.2%97.2M+3648.0%
Acquisitions0.000.000.000.000.00
-43.4M-618.3%8.37M+103.4%4.11M-75.6%16.9M-67.5%51.9M-83.5%
Long-term debt issued0.000.000.000.000.00
Long-term debt repaid0.000.000.000.000.00
Common stock issued0.00+100.0%-6.73M-260.9%4.18M-76.0%17.5M-66.0%51.3M-23.2%
Common stock repurchased0.00-100.0%30.0M0.000.000.00
Dividends paid0.000.000.000.000.00
Other financing activities0.00-100.0%183K+357.7%-71.0K+88.0%-592K0.00
FX effect on cash1.61M+28.3%1.26M+692.5%-212K-125.6%827K+440.5%153K-60.5%
Net change in cash21.4M+106.4%10.4M+109.1%-114M-212.2%101M+532.5%-23.4M-153.9%
Interest paid5.05M+64.1%3.08M-59.3%7.57M+75.4%4.31M+0.0%4.31M+59.3%
Income taxes paid5.06M+63.2%3.10M+61.1%1.92M+367.9%411K+58.1%260K+46.9%
Valuation Ratiosas ofDec 31 ’25as ofDec 31 ’24as ofDec 31 ’23as ofDec 31 ’22as ofDec 31 ’21
Market cap1.50B-37.3%2.39B+24.1%1.93B-33.3%2.89B-69.9%9.61B+60.8%
P/E
————617.6×
P/S1.5×-41.9%2.5×+1.8%2.5×-31.6%3.7×-73.3%13.7×+14.1%
P/B9.7×+6.3%9.1×+48.1%6.1×-10.3%6.9×-69.1%22.2×+36.0%
P/FCF—479.4×—96.1×-2.8%98.9×
Earnings yield
————0.16%
FCF yield—0.21%—1.0%+2.9%1.0%
Source filing10-K10-K10-K10-K10-K

About this data

Source: TNDM’s SEC filings (10-K / 10-Q). Annual columns are as-reported fiscal years; quarterly columns are as-reported fiscal quarters (Q4 derived as full-year minus the first three quarters where a company doesn’t file a standalone Q4); TTM (quarterly) rolls the trailing four quarters at every quarter end, TTM (yearly) samples that one year apart; balance-sheet rows show the period-end balance. Valuation ratios are sampled as of each period end. View all TNDM filings on SEC EDGAR → Not investment advice.